Literature DB >> 8452655

Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance.

P C Comp1.   

Abstract

Coumarin-induced tissue necrosis is a complication of oral anticoagulant therapy characterised by necrosis of the skin and underlying tissue. This occurrence of microvascular thrombosis associated with the administration of an anticoagulant has perplexed the medical and pharmaceutical community since the condition was first recognised in 1943. While the condition is rarely seen, it is of major clinical interest and raises a number of questions concerning pathological mechanisms and patient management. Although some cases occur in patients with hereditary disorders predisposing to thrombosis, the condition remains a mystery in terms of which patients will develop the condition, why the skin and underlying fatty tissues are the target of the microvascular thrombosis, and what the proper approach to a patient with coumarin-induced necrosis should be both in terms of acute management and long term anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452655     DOI: 10.2165/00002018-199308020-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  39 in total

1.  Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate.

Authors:  M Dreyfus; J F Magny; F Bridey; H P Schwarz; C Planché; M Dehan; G Tchernia
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

2.  [Necrosis of the skin after 3 year's treatment with acenocoumarin].

Authors:  A R Cameron; W van Berkel; J J Sixma
Journal:  Ned Tijdschr Geneeskd       Date:  1974-04-06

3.  Coumarin necrosis.

Authors:  J Koch-Weser
Journal:  Ann Intern Med       Date:  1968-06       Impact factor: 25.391

4.  Protein C and the development of skin necrosis during anticoagulant therapy.

Authors:  A W Broekmans; R M Bertina; E A Loeliger; V Hofmann; H G Klingemann
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

5.  Repeated occurrence of skin necrosis twice following coumarin intake and subsequently during decrease of vitamin K dependent coagulation factors associated with cholestasis.

Authors:  V Hofmann; P G Frick
Journal:  Thromb Haemost       Date:  1982-12-27       Impact factor: 5.249

6.  Warfarin induced necrosis of the skin.

Authors:  P A Faraci; R A Deterling; A M Stein; H F Rheinlander; R J Cleveland
Journal:  Surg Gynecol Obstet       Date:  1978-05

7.  Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood.

Authors:  E Marciniak; H D Wilson; R A Marlar
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

Review 8.  Coumarin necrosis--a review of the literature.

Authors:  M S Cole; P K Minifee; F J Wolma
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

9.  Warfarin-induced skin necrosis: report of four cases.

Authors:  J R Horn; L H Danziger; R J Davis
Journal:  Am J Hosp Pharm       Date:  1981-11

10.  Skin necrosis following prolonged administration of coumarin in a patient with inherited protein S deficiency.

Authors:  S L Goldberg; C L Orthner; B L Yalisove; M L Elgart; C M Kessler
Journal:  Am J Hematol       Date:  1991-09       Impact factor: 10.047

View more
  4 in total

1.  Extensive coumarin-induced skin necrosis in a patient with acquired protein C deficiency.

Authors:  L Argaud; C Guerin; L Thomas; G Fournier
Journal:  Intensive Care Med       Date:  2001-09       Impact factor: 17.440

Review 2.  Management of cutaneous drug reactions.

Authors:  K S Babu; Geeta Belgi
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

Review 3.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

4.  The health care setting rather than medical speciality impacts on physicians adherence to guideline-conform anticoagulation in outpatients with non-valvular atrial fibrillation: a cross sectional survey.

Authors:  Bernhard Gerber; Georg Stussi; Thomas Rosemann; Oliver Senn
Journal:  BMC Cardiovasc Disord       Date:  2012-02-29       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.